Miguel Á. Sanz

Research interests

Publications

• Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet

  Blood · 2019 · https://doi.org/10.1182/blood-2019-01-894980

• Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

  New England Journal of Medicine · 2017 · 10.1056/nejmoa1609783

• Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

  New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1614359

• Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

  Blood · 2016 · https://doi.org/10.1182/blood-2016-08-733196

• Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

  Blood · 2011 · 10.1182/blood-2010-08-301796

• Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

  Blood · 2010 · 10.1182/blood-2010-01-266007

• Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience

  Blood · 2009 · 10.1182/blood-2009-07-233387

• Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

  Blood · 2009 · https://doi.org/10.1182/blood-2009-07-235358

• International consensus report on the investigation and management of primary immune thrombocytopenia

  Blood · 2009 · 10.1182/blood-2009-06-225565

• Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin

  Blood · 2008 · 10.1182/blood-2007-07-100669

• Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

  Blood · 2008 · https://doi.org/10.1182/blood-2008-07-162503

• Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

  Blood · 2008 · https://doi.org/10.1182/blood-2008-04-150250

• Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

  The Lancet · 2008 · 10.1016/s0140-6736(08)60203-2

• Comparison of the Results of the Treatment of Adolescents and Young Adults With Standard-Risk Acute Lymphoblastic Leukemia With the Programa Español de Tratamiento en Hematología Pediatric-Based Protocol ALL-96

  Journal of Clinical Oncology · 2008 · 10.1200/jco.2007.13.7265

• Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors

  Blood · 2008 · 10.1182/blood-2008-07-168617

• Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

  Journal of Clinical Oncology · 2003 · https://doi.org/10.1200/jco.2003.04.036

• Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group

  Blood · 2003 · 10.1182/blood-2003-07-2462

• Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

  PubMed · 2000

• Primary Plasma Cell Leukemia: Clinical, Immunophenotypic, DNA Ploidy, and Cytogenetic Characteristics

  Blood · 1999 · 10.1182/blood.v93.3.1032

• A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.

  PubMed · 1999

• A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

  Blood · 1999 · 10.1182/blood.v94.4.1192

• Incidence, Clinical Features, and Outcome of AllTrans-Retinoic Acid Syndrome in 413 Cases of Newly Diagnosed Acute Promyelocytic Leukemia

  Blood · 1998 · 10.1182/blood.v92.8.2712

• A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia

  Blood · 1997 · 10.1182/blood.v90.12.4710

• International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

  Blood · 1997 · https://doi.org/10.1182/blood.v89.6.2079

• Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients

  Blood · 1989 · 10.1182/blood.v74.1.395.395

Current projects

No projects listed.